Test Price
2,800 AED✅ Home Collection Available
INS Gene Type 1 Diabetes Genetic Test in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
Clinical Precision, Regulatory Integrity & Patient-First Care
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection — Available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary Telephonic Post-Test Genetic Counselling & Result Interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The INS Gene Diabetes Mellitus Type 1 Genetic Test screens for pathogenic variants in the insulin (INS) gene linked to early-onset Type 1 diabetes. This next-generation sequencing test is a critical tool for definitive molecular diagnosis, family risk stratification, and informed clinical decision-making. The assay covers all coding exons, flanking intronic regions, and splice sites of the INS gene, delivering high-confidence variant calls through validated bioinformatics pipelines.
| Feature | Our Test (INS NGS) | Closest Alternative |
|---|---|---|
| Precision | Full INS gene coverage (exons, splice sites) via NGS | Multi-gene panel, may miss rare INS variants |
| Methodology | Next-Generation Sequencing (NGS) with validated bioinformatics | Sanger sequencing (limited throughput) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403: “This test identifies genetic susceptibility to early-onset Type 1 diabetes through comprehensive INS gene analysis. A positive result indicates elevated risk, not an active diagnosis — complete clinical evaluation including glucose monitoring and autoantibody panels remains essential. Never interpret this report alone; always discuss findings with your endocrinologist for a tailored, evidence-based care plan.”
Medication Advisory
Do not discontinue or alter any prescribed medication — including insulin, oral hypoglycemics, or other therapies — without direct consultation with your treating physician. Genetic test results do not supersede current therapeutic requirements. Always maintain your prescribed regimen until your healthcare provider advises otherwise.
Patient Safety & Exclusion Criteria
- Exclusion: Allogeneic bone marrow transplant within the past 12 months, recent blood transfusion (<4 weeks), or active hematologic malignancy may compromise result accuracy.
- Emergency Red Flags: If you experience sudden polyuria, polydipsia, unexplained weight loss, fruity-scented breath, or confusion after receiving results, seek emergency medical attention immediately — these may signal diabetic ketoacidosis.
- Pre-Test Requirement: A mandatory genetic counselling session and pedigree chart construction must be completed prior to sample collection per DHA standards.
Patient FAQ & Clinical Guidance
1. Who should consider the INS Gene Type 1 Diabetes NGS Test?
This test is recommended for individuals with a strong family history of Type 1 diabetes, early-onset hyperglycemia, or unexplained metabolic disturbances. It is particularly valuable for pediatric patients, young adults, and asymptomatic relatives of an affected proband, especially when autoantibody screening is inconclusive. Your diabetologist may also use the result to distinguish Type 1 from Type 2 diabetes in atypical presentations.
2. How is the sample collected and what preparation is required?
A simple blood draw, buccal swab, or one drop of blood on an FTA card is collected at home by a certified phlebotomist through our VIP Mobile Phlebotomy service. No fasting is strictly required; however, a mandatory pre-test genetic counselling session where a pedigree chart is drawn must be completed before collection. This session ensures you fully understand the implications and enables accurate variant interpretation. Please inform us of any recent transfusions or bone marrow procedures.
3. Are my genetic data private and compliant with UAE law?
Yes, your data is strictly protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. We process all samples within our ISO-certified facility and never share identifiable genetic information without explicit consent. Results are delivered only through encrypted channels, and our genetic counsellors ensure parental or legal guardian consent is documented for minors, in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed under strict confidentiality protocols, and identifiable information is never shared without documented patient consent. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your trust and privacy are foundational to every test we perform.
Clinical & Logistical Metadata
| Test Name | INS Gene Type 1 Diabetes Genetic Test |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood, Buccal Swab, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | E10.9 |
| LOINC Code | 77936-6 |
| DHA Facility License & Laboratory Address | DHA License 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians